To systematically evaluate the efficacy of inorganic trioxide aggregate (MTA) and Biodentine in pulpotomy of mastoid molars. PubMed, The Cochrane Library, Embase, Scopus, CNKI, and WanFang databases were searched for randomized controlled trials (RCTs) of the efficacy of MTA and Biodentine in molar pulpotomy in English only, with a search period ending in September 2022, and outcome indicators including clinical success and imaging success rates. A meta-analysis was performed according to the Cochrane systematic review using Revman 5.3 software. A total of 9 studies with 450 teeth were included. Meta-analysis results showed no statistically significant differences in clinical success rates and imaging success rates at 6, 12, and 24 months in the MTA group compared with the Biodentine group. There were no significant differences in clinical success and imaging success rates between MTA and Biodentine compared to molar pulpotomy, and no one material was superior to the other, and the above conclusions need to be validated by a large number of RCTs due to the quality and number of studies.

Cheng Mengke, Chen Yilei, Liu Jia. Effectiveness of MTA and Biodentine for Pulpotomy of Molars: A Meta-Analysis. Academic Journal of Medicine & Health Sciences (2023) Vol. 4, Issue 8: 91-98. https://doi.org/10.25236/AJMHS.2023.040815.

[1] Duncan H F, Galler K M, Tomson P L, et al. European Society of Endodontology position statement: management of deep caries and the exposed pulp [J]. Int Endod J, 2019, 52(7): 923-34.

[2] Camilleri,Josette.Staining Potential of Neo MTA Plus, MTA Plus, and Biodentine Used for Pulpotomy Procedures[J].Journal of Endodontics Official Journal of American Association of Endodontists, 2015.

[3] Parirokh M, Torabinejad M. Mineral trioxide aggregate: a comprehensive literature review--Part III: Clinical applications, drawbacks, and mechanism of action [J]. J Endod, 2010, 36(3): 400-413.

[4] Camilleri J. Color stability of white mineral trioxide aggregate in contact with hypochlorite solution [J]. J Endod, 2014, 40(3): 436-440.

[5] Camilleri J, Sorrentino F, Damidot D. Investigation of the hydration and bioactivity of radiopacified tricalcium silicate cement, Biodentine and MTA Angelus [J]. Dent Mater, 2013, 29(5): 580-593.

[6] Junior E S ,Manuela Gouvêa Campêlo dos Santos, Oliveira L B ,et al.MTA and biodentine for primary teeth pulpotomy: a systematic review and meta-analysis of clinical trials[J].Clinical Oral Investigations, 2019.DOI:10.1007/s00784-018-2616-6. 

[7] Goupy L. Biodentin: a novel dentine substitute for use in paediatric conservative dentistry [J]. Septodont Case Studies Collection, 2012, 1: 10-16.

[8] Rubanenko M, Moskovitz M, Petel R, et al. Effectiveness of biodentine versus formocresol as dressing agents in pulpotomized primary molars. Preliminary results; proceedings of the 12th congress of EAPD, Sopot, Poland, F, 2014 [C].

[9] Nowicka A, Wilk G, Lipski M, et al. Tomographic Evaluation of Reparative Dentin Formation after Direct Pulp Capping with Ca(OH)2, MTA, Biodentine, and Dentin Bonding System in Human Teeth [J]. J Endod, 2015, 41(8): 1234-1240.

[10] Laurent P, Camps J, About I. Biodentine(TM) induces TGF-β1 release from human pulp cells and early dental pulp mineralization [J]. Int Endod J, 2012, 45(5): 439-448.

[11] Andrei M, Vacaru R P, Coricovac A, et al. The Effect of Calcium-Silicate Cements on Reparative Dentinogenesis Following Direct Pulp Capping on Animal Models [J]. Molecules, 2021, 26(9).

[12] Cosme-Silva L, Dal-Fabbro R, Gonçalves L O, et al. Hypertension affects the biocompatibility and biomineralization of MTA, High-plasticity MTA, and Biodentine® [J]. Braz Oral Res, 2019, 33: e060.

[13] Ahuja S, Surabhi K, Gandhi K, et al. Comparative evaluation of success of biodentine and mineral trioxide aggregate with formocresol as pulpotomy medicaments in primary molars: An in vivo study [J]. International Journal of Clinical Pediatric Dentistry, 2020, 13(2): 167-173.

[14] Bani M, Aktaş N, Çınar Ç, et al. The Clinical and Radiographic Success of Primary Molar Pulpotomy Using Biodentine™ and Mineral Trioxide Aggregate: A 24- Month Randomized Clinical Trial [J]. Pediatr Dent, 2017, 39(4): 284-288.

[15] Carti O, Oznurhan F. Evaluation and comparison of mineral trioxide aggregate and biodentine in primary tooth pulpotomy: clinical and radiographic study [J]. Niger J Clin Pract, 2017, 20(12): 1604-1609.

[16] Çelik B N, Mutluay M S, Arıkan V, et al. The evaluation of MTA and Biodentine as a pulpotomy materials for carious exposures in primary teeth [J]. Clin Oral Investig, 2019, 23(2): 661-666.

[17] Cuadros-Fernández C, Lorente Rodríguez A I, Sáez-Martínez S, et al. Short-term treatment outcome of pulpotomies in primary molars using mineral trioxide aggregate and Biodentine: a randomized clinical trial [J]. Clin Oral Investig, 2016, 20(7): 1639-1645.

[18] Juneja P, Kulkarni S. Clinical and radiographic comparison of biodentine, mineral trioxide aggregate and formocresol as pulpotomy agents in primary molars [J]. European Archives of Paediatric Dentistry, 2017, 18(4): 271-278.

[19] Kusum B, Rakesh K, Richa K. Clinical and radiographical evaluation of mineral trioxide aggregate, biodentine and propolis as pulpotomy medicaments in primary teeth [J]. Restorative dentistry & endodontics, 2015, 40(4): 276-285.

[20] Rajasekharan S, Martens L C, Vandenbulcke J, et al. Efficacy of three different pulpotomy agents in primary molars: a randomized control trial [J]. International Endodontic Journal, 2017, 50(3): 215-228.

[21] Ramanandvignesh P, Kumar G, Mridula D J K G. Clinical and radiographic evaluation of pulpotomy using mta, biodentine and er,cr:Ysgg laser in primary teeth- a clinical study [J]. Laser Therapy, 2020, 29(1): 29-34.

[22] Dhar V, Marghalani A A, Crystal Y O, et al. Use of Vital Pulp Therapies in Primary Teeth with Deep Caries Lesion (vol 39, pg 146, 2017) [J]. Pediatric dentistry, 2020, (42-1).

[23] Peng L, Ye L, Guo X, et al. Evaluation of formocresol versus ferric sulphate primary molar pulpotomy: a systematic review and meta-analysis [J]. Int Endod J, 2007, 40(10): 751-757.

[24] Da Rosa W L O, Cocco A R, Silva T M D, et al. Current trends and future perspectives of dental pulp capping materials: a systematic review [J]. J Biomed Mater Res B Appl Biomater, 2018, 106(3): 1358-1368.

[25] Sharaf AA, Farsi NM (2004) A clinical and radiographic evaluation of stainless steel crowns for primary molars. j Dent 32:27-33

[26] Kalaskar RR, Damle SG. Comparative evaluation of lyophilized freeze dried platelet derived preparation with calcium hydroxide as pulpotomy agents in J Indian Soc Pedod Prev Dent. 2004;22(1):24-29.

[27] Oliveria TM, Moretti ABS, Sakai VT, et al. Clinical, radiographic and histologic analysis of the effects of pulp capping materials used in pulpotomies of human primary teeth. Eur Arch Pediatr Dent. 2013;14:65-71.